Already registered for Bio€quity Europe?

In-Person Passes Sold Out; Register for Digital Pass (May 2, 2022) Due to record demand, Bio€quity Europe in Milan is sold out. We encourage you to register instead for a Digital Access Pass. The Digital Pass allows you to schedule virtual 1x1 meetings with Bio€quity delegates over two bonus days (May 23-24), plus watch all session & presentation recordings for 30 days after the event. Digital attendees also receive BioCentury’s 2nd Annual Scene Setter report, McKinsey’s Bio€quity conference report and complimentary access to BioCentury’s BCIQ database.

Europe’s premier international showcase for financial dealmakers and biopharma executives to meet rising biotechs – join the discussion in Milan*, or attend from home via a digital pass. Plus take advantage of two bonus days of digital 1x1 meetings.

* Due to record demand, Bio€quity Europe in Milan is sold out. We encourage you to register instead for a Digital Access Pass.



Navigating Through Talent & Capital Headwinds

  • Bio€quity Europe revives face-to-face financial networking in 2022 with “Navigating Through Talent & Capital Headwinds.”
  • Rich in science and benefitting from the recent global flood of capital, European biotech now faces two headwinds: The Talent Crunch and prospects of a Capital Crunch.
  • The Talent Crunch: European biotech faces the hard reality faced everywhere: Talent has become the rate-limiting factor to building a globally competitive innovation ecosystem.
  • The Capital Crunch: After the longest bull run in biotech history, concerns are rising - What will it take to keep investors in the sector?
  • Once again, Bio€quity Europe challenges its community to identify solutions to industry pain points, and to build a strategy that will sustain Europe’s innovation engine into the future.

Join your colleagues for the 22nd Bio€quity Europe as biopharma leaders debate industry headwinds, and discuss how to gain the upper hand in a global competition for talent and capital.

Why Attend?

  • Debate strategies for navigating through talent and capital headwinds over two-plus days of strategic panels and workshops.
  • Understand key talent and capital trends via an exclusive report from Insights Partner, McKinsey & Co.
  • Hear from 100+ rising biotechs selected by the BioCentury team.
  • Meet 1x1 with potential investors and partners using EBD's partneringONE® System – two days in-person (May 17-18), plus two days digital (May 23-24).
  • Network with peers from across the innovation ecosystem.
  • Use BioCentury’s BCIQ database to research companies and help prepare for 1x1 meetings.
  • Watch all session/presentation recordings for 30 days after the event.
  • Your choice: Full-Access Pass* or Digital Pass?
    * Due to record demand, Bio€quity Europe in Milan is sold out. We encourage you to register instead for a Digital Access Pass.

Explore Bio€quity Europe

Bio€quity Europe 2022 will be held at the Meliá Milano - May 16-18, 2022Meliá Milano Via Masaccio, 19, 20149 Milano MI, Italy

Bio€quity Europe 2022 Faculty

Antoine Papiernik
Chairman & Managing Partner
Sofinnova Partners
Alexandra Zemp, Ph.D.
Partner
McKinsey & Company
David Flores
Co-Founder, President & CEO
BioCentury Inc.
Valerio De Molli
Managing Partner & CEO
The European House - Ambrosetti
Karen Bernstein, Ph.D.
Co-Founder & Chairman
BioCentury Inc.
View More Faculty
right-arrow

Bio€quity Europe 2022 Sponsors

More
right-arrow
Sponsorship opportunities available for Bio€quity Europe 2022Speak with a BioCentury representative today

Bio€quity Europe 2022 Presenters

More
right-arrow
Interested in becoming a Presenting Company for the next Bio€quity Europe in Milan?Apply now to be considered for the Bio€quity Europe Class of 2022

Testimonials

“Bio€quity Europe is a 'must go' for both VCs and CEOs of life science companies in Europe ... it is THE event where you can feel the pulse of the industry ...”

Antoine Papiernik
Chairman & Managing Partner
Sofinnova Partners

"Bio€quity is for me the most important investor conference for life science in Europe. If you want to know how the investor community ticks and want to meet the most important companies and rising future stars in Europe it´s the place to be." ​

Harald Poth, Ph.D.
Senior Investment Manager
LBBW Venture​

"If you are a VC or biotech CEO in Europe this is the conference to attend. Bio€quity is a great venue bringing the relevant players together. It’s not too big, not too small and it’s THE place to network." ​

Christina Takke, Ph.D.
Managing Partner
V-Bio Ventures​